Cancer patients warned against toxic 'vitamin B17' miracle cure

Cancer patients should be careful not to believe everything they read online. (Lukas Coch/AAP PHOTOS)

What was claimed

'Vitamin B17' cures cancer.

Our verdict

False. Research has repeatedly shown B17 to be ineffective as a human cancer treatment.

AAP FACTCHECK – Cancer sufferers are being targeted by claims that a substance misleadingly known as “vitamin B17” could be a miracle cure for their illness.

The claim is false. Also known by the name laetrile, “vitamin B17” is not a vitamin at all. It is a semi-synthetic form of amygdalin, a natural substance found in some nuts, plants and fruit seeds. 

One Facebook post claims “Vitamin B17 was banned by the FDA because it cures cancer!”, while others refer to B17 fighting cancer as well as killing cancer or cancer cells.

Crossed out Facebook post about
There are hundreds of posts across social media about "vitamin B17" supposedly curing cancer.

The substance, however, has never been shown to be effective as a cancer treatment and can cause serious harm if ingested.

Some of the claims on social media come from people selling “vitamin B17” pills or promoting alternative medicines

When processing amygdalin, the human body releases cyanide, a potentially deadly chemical that impedes the body’s ability to use oxygen. 

As a result, people who self-medicate with amygdalin may suffer fever, headaches, organ damage or even death. 

Amygdalin has been a schedule 10 prohibited substance (poison) in Australia since 1974 due to its “serious toxicity and no clear evidence of therapeutic benefit”. 

It’s also banned in the US and Europe

A 2015 systematic review studythe gold standard of scientific research – concluded that clinical data did not support claims about amygdalin’s beneficial effects for cancer patients. 

Cancer tumour cell.
Treatments for cancer are always carefully researched.

The review found that instead, ingesting it comes with “a considerable risk” of serious adverse effects from cyanide poisoning. 

“The risk-benefit balance of laetrile or amygdalin as a treatment for cancer is therefore unambiguously negative,” the review said. 

The toxicity of amygdalin has been known for a long time. 

A 1982 study published in the prestigious New England Journal of Medicine reported that cancer patients treated with an amygdalin therapy program had “no substantive benefit … in terms of cure, improvement, or stabilization of cancer, improvement of symptoms related to cancer, or extension of life span”. 

Several patients in the study showed symptoms of cyanide poisoning “approaching the lethal range”. 

More recent studies have similarly described cancer patients suffering severe cyanide poisoning and organ failure after ingesting amygdalin. 

In 2020, three people in New Zealand needed hospital treatment after consuming raw apricot seeds that contained amygdalin. 

Adrian Harris, Emeritus Professor of Medical Oncology at Oxford University, previously told AAP FactCheck “vitamin B17” can cause poisoning, especially if taken in tablet form, while Ian Olver AM, a cancer researcher at the University of Adelaide and a former Cancer Council chief executive, said the cyanide produced by amygdalin kills cells regardless of whether they’re cancerous.

Hand wearing a rubber glove and holding white capsules.
Amygdalin can come in various forms.

Globally, cancer research bodies strongly advise people not to ingest amygdalin pills. 

The US National Cancer Institute has said no controlled clinical trials of laetrile have been reported, and anecdotal reports “have not shown it to be an effective treatment for cancer”.

Australia’s Cancer Council said it is “not only ineffective at treating cancer but could also be very dangerous”. 

AAP FactCheck previously debunked claims that people from Pakistan’s Hunza Valley are “the only people in the world without cancer” because they eat apricot seeds containing “vitamin B17”. 

False claims about “vitamin B17” curing cancer have also been debunked by fact-checkers at Health Feedback and Full Fact.

The Verdict

False – The claim is inaccurate.

AAP FactCheck is an accredited member of the International Fact-Checking Network. To keep up with our latest fact checks, follow us on Facebook, Twitter and Instagram.

What is AAPNews?

For the first time, Australian Associated Press is delivering news straight to the consumer.

No ads. No spin. News straight-up.

Not only do you get to enjoy high-quality news delivered straight to your desktop or device, you do so in the knowledge you are supporting media diversity in Australia.

AAP Is Australia’s only independent newswire service, free from political and commercial influence, producing fact-based public interest journalism across a range of topics including politics, courts, sport, finance and entertainment.

What is AAPNews?
The Morning Wire

Wake up to AAPNews’ morning news bulletin delivered straight to your inbox or mobile device, bringing you up to speed with all that has happened overnight at home and abroad, as well as setting you up what the day has in store.

AAPNews Morning Wire
AAPNews Breaking News
Breaking News

Be the first to know when major breaking news happens.


Notifications will be sent to your device whenever a big story breaks, ensuring you are never in the dark when the talking points happen.

Focused Content

Enjoy the best of AAP’s specialised Topics in Focus. AAP has reporters dedicated to bringing you hard news and feature content across a range of specialised topics including Environment, Agriculture, Future Economies, Arts and Refugee Issues.

AAPNews Focussed Content
Subscription Plans

Choose the plan that best fits your needs. AAPNews offers two basic subscriptions, all billed monthly.

Once you sign up, you will have seven days to test out the service before being billed.

AAPNews Full Access Plan
Full Access
AU$10
  • Enjoy all that AAPNews has to offer
  • Access to breaking news notifications and bulletins
  • Includes access to all AAPNews’ specialised topics
Join Now
AAPNews Student Access Plan
Student Access
AU$5
  • Gain access via a verified student email account
  • Enjoy all the benefits of the ‘Full Access’ plan at a reduced rate
  • Subscription renews each month
Join Now
AAPNews Annual Access Plan
Annual Access
AU$99
  • All the benefits of the 'Full Access' subscription at a discounted rate
  • Subscription automatically renews after 12 months
Join Now

AAPNews also offers enterprise deals for businesses so you can provide an AAPNews account for your team, organisation or customers. Click here to contact AAP to sign-up your business today.

SEVEN DAYS FREE
Download the app
Download AAPNews on the App StoreDownload AAPNews on the Google Play Store